Hydrogel precursor solution and preparation method thereof, hydrogel and application thereof
Hydrogels are solved by using the pore-forming phase of polyethylene oxide and gelatin in hydrogel materials and gelatin such as methacrylylated gelatin, combined with convection mixing and UV photocrosslinking or 3D printing technology. The problem of poor material stability has achieved stable hydrogel preparation and effective use in biomedical applications.
Patent Information
- Application Number
- CN202311550438.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-11-21
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2043-11-21
AI Technical Summary
Existing hydrogel materials have poor stability when forming micropores, which are prone to stratification, affecting their use in biomedical applications.
By mixing the pore-forming phase and the gel phase, the pore-forming phase contains polyethylene oxide and gelatin, and the gel phase contains methacrylylated gelatin, acrylamide and phenyl-2,4,6-trimethylbenzoyl sub-sub-2,4,6-trimethylbenzoyl sub-sub- Lithium phosphate is used to prepare hydrogel precursor by convection mixing method and UV photocrosslinking or 3D printing technology to form a stable hydrogel.
Improve the stability of hydrogel precursor, avoid stratification, provide pore structure suitable for cell growth, enhance the mechanical properties and degradation time of hydrogel, and is suitable for adipose tissue, bone, articular cartilage and wound repair, etc. application.
Smart Images

Figure CN117586636B_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of biomaterials, and in particular to a hydrogel precursor solution and a preparation method thereof, a hydrogel and applications thereof. Background Art
[0002] Hydrogel is a polymer material with a three-dimensional porous structure. It has the characteristics of good hydrophilicity, high viscoelasticity, and good biocompatibility. These properties make the application of hydrogel in the biomedical field have broad development prospects. In the human body, except for bones, teeth, nails and the outer layer of skin, most tissues are gel materials composed of protein and polysaccharide networks containing a large amount of water. In the biomedical field, hydrogel materials are often used for bone and joint cartilage repair, wound repair, rescue of heart necrosis, drug delivery, etc.
[0003] However, some existing hydrogel materials generally use pure methacrylated gelatin (Gelma for short) or use methacrylated hyaluronic acid (HAMA for short), polyethylene glycol diacrylate (PEGDA for short) and the like to modify Gelma. In order to form micropores in the hydrogel, the inventors of the present application also added polyethylene oxide as a pore-forming phase. However, it was found in experiments that the hydrogel precursor solution obtained in this way has poor stability and is prone to stratification. Summary of the invention
[0004] The present application provides a hydrogel precursor solution and a preparation method thereof, a hydrogel and an application thereof. The hydrogel precursor solution has good stability and is not prone to stratification.
[0005] This application is implemented as follows:
[0006] In a first aspect, the present application provides a hydrogel precursor solution, which is formed by mixing a pore-forming phase and a gel phase; the pore-forming phase contains polyethylene oxide and gelatin, and the gel phase contains methacryloyl gelatin.
[0007] In a possible embodiment, the mass concentration of the polyethylene oxide in the pore-forming phase is 0.005 to 0.03 g / ml, and the mass concentration of the gelatin in the pore-forming phase is 0.05 to 0.12 g / ml.
[0008] In one possible embodiment, the gelatin in the pore-forming phase is pig skin gelatin.
[0009] In a possible embodiment, the gel phase further contains acrylamide and phenyl-2,4,6-trimethylbenzoyl lithium phosphite;
[0010] Optionally, the mass concentration of the methacryloyl gelatin in the gel phase is 0.06-0.12 g / ml, the mass concentration of the acrylamide in the gel phase is 0.02-0.04 g / ml, and the mass concentration of the phenyl-2,4,6-trimethylbenzoyl lithium phosphite in the gel phase is 0.003-0.01 g / ml.
[0011] In a possible implementation manner, the mass ratio of the pore-forming phase to the gel phase is 1-3:1-3.
[0012] In one possible embodiment, the pore-forming phase is loaded with human adipose stem cells.
[0013] In a second aspect, the present application provides a method for preparing a hydrogel precursor solution as in the first aspect, comprising the following steps: uniformly mixing the pore-forming phase and the gel phase to obtain a hydrogel precursor solution.
[0014] In a possible embodiment, the pore-forming phase is divided into a first portion and a second portion, and the first portion of the pore-forming phase is mixed evenly with the gel phase and then mixed with the second portion of the pore-forming phase.
[0015] In a third aspect, the present application provides a hydrogel, which is prepared by UV light cross-linking or 3D printing of the hydrogel precursor solution described in the second aspect and then soaking it in a culture medium.
[0016] In a fourth aspect, the present application provides a use of the hydrogel as described in the third aspect in the preparation of adipose tissue filling and repair materials, bone repair materials, articular cartilage repair materials or wound repair materials.
[0017] The embodiments of the present application have at least the following beneficial effects:
[0018] The hydrogel precursor of the present application contains polyethylene oxide and gelatin in the pore-forming phase, which makes it close to the viscosity of the gel phase, so that the hydrogel precursor obtained by mixing the pore-forming phase and the gel phase is not easy to stratify and has good stability.
[0019] The preparation method of the hydrogel precursor solution of the present application mixes the pore-forming phase and the gel phase by convection mixing to generate certain pores, thereby providing a place for cell extension and proliferation.
[0020] The hydrogel of the present application can be customized when the hydrogel precursor is prepared by 3D printing to prepare a hydrogel with a certain macroscopic pore structure; nanoscale pores can be generated by UV cross-linking the hydrogel precursor; the hydrogel precursor is immersed in a culture medium after UV light cross-linking or 3D printing, so that the polyethylene oxide and gelatin in the pore-forming phase are dissolved, thereby forming a micron-scale pore structure, and cells grow in the formed pores. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings required for use in the embodiments will be briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present application and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without paying creative work.
[0022] Figure 1 These are photos of the pore-forming phase and the gel phase of Example 1, Example 7, Example 8 and Comparative Example 1 of the present application after mixing and standing;
[0023] Figure 2 This is a SEM image of the hydrogel of Example 2 of the present application;
[0024] Figure 3 The stress-strain curves of the hydrogels of Examples 2 to 4 of the present application;
[0025] Figure 4 This is a test result diagram of the Young's modulus of the hydrogels of Examples 2 to 4 of the present application;
[0026] Figure 5 This is a graph showing the results of an in vitro degradation experiment of the hydrogel of Example 2 of the present application;
[0027] Figure 6 This is a graph showing the pore structure size results of the hydrogels of Examples 2 to 4 of the present application;
[0028] Figure 7 This is a diagram showing the pore structure distribution of the hydrogels of Examples 2, 5 and 6 of the present application;
[0029] Figure 8 This is an optical microscope image of the hydrogel of Example 2 of the present application;
[0030] Fig. 9 This is a fluorescence microscopy image of the hydrogel of Example 2 of the present application;
[0031] Fig.10 This is a graph showing the biocompatibility test results of the hydrogel in Example 2 of the present application;
[0032] Fig.11 This is a diagram showing the cell stretching results of the hydrogel of Example 2 of the present application;
[0033] Fig.12 This is the 4-day cell proliferation result of the hydrogel in Example 2 of the present application
[0034] Fig.13 This is a graph showing the 7-day cell proliferation results of the hydrogel of Example 2 of the present application;
[0035] Fig.14 These are HE staining images of sections of the implanted sites of rats after 1 week and 2 weeks of hydrogel implantation experiment in Example 2 of the present application. DETAILED DESCRIPTION
[0036] The embodiments of the present application will be described in detail below in conjunction with the examples, but it will be appreciated by those skilled in the art that the following examples are only used to illustrate the present application and should not be considered as limiting the scope of the present application. In the examples, if specific conditions are not specified, they are carried out according to normal conditions or the conditions recommended by the manufacturer. If the manufacturer is not specified for the reagents or instruments used, they are all conventional products that can be purchased commercially.
[0037] The following is a detailed description of the hydrogel precursor solution and its preparation method, the hydrogel and its application in the embodiments of the present application:
[0038] In a first aspect, the present application provides a hydrogel precursor solution, which is a mixture of a pore-forming phase and a gel phase; the pore-forming phase contains polyethylene oxide and gelatin, and the gel phase contains methacryloyl gelatin.
[0039] The hydrogel precursor of the present application contains polyethylene oxide and gelatin in the pore-forming phase, so that the viscosity is close to that of the gel phase, so that the hydrogel precursor obtained by mixing the pore-forming phase and the gel phase is not easy to stratify and has good stability. The inventors of the present application found in the study that when the pore-forming phase does not contain gelatin, the pore-forming phase and the gel phase are easily stratified after being evenly mixed and allowed to stand, and when the pore-forming phase contains gelatin, the pore-forming phase and the gel phase are not easy to stratify after being evenly mixed and allowed to stand. Optionally, the gelatin in the pore-forming phase is pigskin gelatin, that is, gelatin made from pigskin as raw material.
[0040] The mass ratio of the pore-forming phase to the gel phase is 1-3:1-3, for example, 1:1, 1:2, 1:3, 2:1, 2:3, 3:1 or 3:2.
[0041] Exemplarily, the mass concentration of polyethylene oxide in the pore-forming phase is 0.005-0.03 g / ml, for example, any one of 0.005 g / ml, 0.01 g / ml, 0.015 g / ml, 0.02 g / ml, 0.025 g / ml and 0.03 g / ml, or a value between any two of them.
[0042] Exemplarily, the mass concentration of gelatin in the pore-forming phase is 0.05-0.12 g / ml, for example, any one of 0.05 g / ml, 0.06 g / ml, 0.07 g / ml, 0.08 g / ml, 0.09 g / ml, 0.10 g / ml, 0.11 g / ml and 0.12 g / ml, or a value between any two of them.
[0043] Among them, most of the research on hydrogels is used for "bone and articular cartilage repair", "wound repair", "saving heart necrosis", "carrying drugs", etc., and less common in "adipose tissue filling and repair" related research. Adipose tissue filling and repair requires it to have better toughness, longer degradation time, etc. Furthermore, in order to improve the mechanical properties of hydrogels and prolong the degradation time, in this application, the gel phase also contains acrylamide and phenyl-2,4,6-trimethylbenzoyl lithium phosphite. It has been verified experimentally that the addition of acrylamide can effectively improve the mechanical properties of hydrogels made from hydrogel precursors and prolong the degradation time.
[0044] Optionally, the mass concentration of methacryloyl gelatin in the gel phase is 0.06-0.12 g / ml, the mass concentration of acrylamide in the gel phase is 0.02-0.04 g / ml, and the mass concentration of phenyl-2,4,6-trimethylbenzoyl lithium phosphite in the gel phase is 0.003-0.01 g / ml.
[0045] Illustratively, the mass concentration of methacryloyl gelatin in the gel phase is any one of 0.06 g / ml, 0.07 g / ml, 0.08 g / ml, 0.09 g / ml, 0.10 g / ml, 0.11 g / ml and 0.12 g / ml, or a value between any two of them.
[0046] Illustratively, the mass concentration of acrylamide in the gel phase is 0.02 g / ml, 0.025 g / ml, 0.03 g / ml, 0.035 g / ml or 0.04 g / ml.
[0047] Illustratively, the mass concentration of phenyl-2,4,6-trimethylbenzoyl lithium phosphite in the gel phase is any one of 0.003 g / ml, 0.004 g / ml, 0.005 g / ml, 0.006 g / ml, 0.007 g / ml, 0.008 g / ml, 0.009 g / ml and 0.01 g / ml, or a value between any two of them.
[0048] Furthermore, the pore-forming phase is also loaded with human adipose stem cells, which can not only play a role in fat filling, but also play a role in fat repair. During the preparation, the cultured human adipose stem cells can be centrifuged and then mixed with polyethylene oxide and gelatin, so that the pore-forming phase is loaded with human adipose stem cells.
[0049] In a second aspect, the present application provides a method for preparing a hydrogel precursor solution, which comprises the following steps: uniformly mixing the pore-forming phase and the gel phase to obtain a hydrogel precursor solution.
[0050] Since the pore-forming phase contains polyethylene oxide and gelatin, its viscosity is close to that of the gel phase, so that the pore-forming phase and the gel phase are not easy to separate after being evenly mixed, and the stability is better.
[0051] In some embodiments, the pore-forming phase is divided into a first portion and a second portion, and the first portion of the pore-forming phase is mixed with the gel phase uniformly before being mixed with the second portion of the pore-forming phase. It is understood that in other embodiments, other methods of mixing may be used, such as directly mixing all the pore-forming phases with all the gel phases, as long as the pore-forming phase and the gel phase can be uniformly mixed.
[0052] Optionally, the pore-forming phase and the gel phase are mixed by convection mixing, and the convection mixing time is 2 to 10 seconds. The pore-forming phase and the gel phase are mixed by convection mixing to produce certain pores, providing a place for cell extension and proliferation. Among them, the convection mixing time will affect the formation of pores, and the convection mixing time can be selected according to the needs of porosity. In addition, in other embodiments, other mixing methods can also be used, as long as the pore-forming phase and the gel phase can be mixed evenly.
[0053] In a third aspect, the present application provides a hydrogel, which is prepared by UV light cross-linking or 3D printing of the above-mentioned hydrogel precursor solution and then soaking it in a culture medium.
[0054] When the hydrogel precursor is prepared by 3D printing, personalized customization can be achieved to prepare a hydrogel with a certain macroscopic pore structure. Nanoscale pores can be produced by UV crosslinking of the hydrogel precursor; the hydrogel precursor is immersed in the culture medium after UV light crosslinking or 3D printing, the gel phase is formed, and the polyethylene oxide and gelatin of the pore-forming phase are dissolved, thereby forming a micron-scale pore structure, and the cells grow in the formed pores. As a result, the hydrogel of the present application has different types of pore structures.
[0055] In a fourth aspect, the present application provides an application of a hydrogel in the preparation of adipose tissue filling and repair materials, bone repair materials, articular cartilage repair materials or wound repair materials.
[0056] The hydrogel precursor solution and preparation method thereof, the hydrogel and application thereof of the present application are further described in detail below in conjunction with the embodiments.
[0057] Example 1
[0058] The present embodiment provides a hydrogel precursor solution, which is a mixture of a pore-forming phase and a gel phase, the mass ratio of the pore-forming phase to the gel phase is 1:1, the gel phase contains 0.1 g / ml of methacryloyl gelatin (GelMA), and the pore-forming phase contains 0.016 g / ml of polyethylene oxide and 0.084 g / ml of pig skin gelatin.
[0059] The preparation step of the hydrogel precursor solution comprises: mixing the pore-forming phase and the gel phase in a countercurrent manner for 5 seconds.
[0060] It was observed that the pore-forming phase and the gel phase were stratified when they were just mixed together, but there was no stratification when they were mixed evenly by convection, and there was no stratification after standing for 15 minutes (refer to Figure 1 The results in the third row).
[0061] Example 2
[0062] The present embodiment provides a hydrogel precursor solution, which is a mixture of a pore-forming phase and a gel phase, the mass ratio of the pore-forming phase to the gel phase is 1:1, the gel phase contains 0.08 g / ml of methacryloyl gelatin (GelMA), 0.02 g / ml of acrylamide (AM) and 0.005 g / ml of phenyl-2,4,6-trimethylbenzoyl lithium phosphite (LAP), and the pore-forming phase contains 0.016 g / ml of polyethylene oxide and 0.084 g / ml of pig skin gelatin.
[0063] The preparation step of the hydrogel precursor solution comprises: mixing the pore-forming phase and the gel in a relative flow manner for 4 seconds.
[0064] This embodiment also provides a hydrogel, which is formed by washing away the pore-forming phase after 3D printing the hydrogel precursor liquid.
[0065] Example 3
[0066] This embodiment provides a hydrogel precursor solution and a hydrogel. Compared with Embodiment 2, the only difference is that the acrylamide in the gel phase is 0.04 g / ml.
[0067] Example 4
[0068] This embodiment provides a hydrogel precursor solution and a hydrogel. Compared with Embodiment 2, the only difference is that the gel phase does not contain acrylamide.
[0069] Example 5
[0070] This embodiment provides a hydrogel precursor solution and a hydrogel. Compared with Embodiment 2, the only difference is that the convection mixing time in the preparation step of the hydrogel precursor solution is 6 seconds.
[0071] Example 6
[0072] This embodiment provides a hydrogel precursor solution and a hydrogel. Compared with Embodiment 2, the only difference is that the convection mixing time in the preparation step of the hydrogel precursor solution is 8 seconds.
[0073] Example 7
[0074] This embodiment provides a hydrogel precursor solution, which is different from that of embodiment 1 only in that the amount of pigskin gelatin in the pore-forming phase is 0.12 g / ml.
[0075] It was observed that the pore-forming phase and the gel phase were stratified when they were just mixed together, but there was no stratification when they were mixed evenly by convection, and there was no stratification after standing for 8 minutes (refer to Figure 1 The fourth row of results).
[0076] Example 8
[0077] This embodiment provides a hydrogel precursor solution, which is different from that of embodiment 1 only in that the amount of pigskin gelatin in the pore-forming phase is 0.05 g / ml.
[0078] It was observed that the pore-forming phase and the gel phase were stratified when they were just mixed together, but there was no stratification when they were mixed evenly by convection, and there was no stratification after standing for 8 minutes (refer to Figure 1 (results in the second row).
[0079] Comparative Example 1
[0080] This comparative example provides a hydrogel precursor solution, which is a mixture of a pore-forming phase and a gel phase, the mass ratio of the pore-forming phase to the gel phase is 1:1, the gel phase contains 0.1 g / ml of methacryloyl gelatin (GelMA), and the pore-forming phase contains 0.016 g / ml of polyethylene oxide.
[0081] The preparation step of the hydrogel precursor solution comprises: mixing the pore-forming phase and the gel phase in a countercurrent manner for 5 seconds.
[0082] It was observed that the pore-forming phase and the gel phase were separated when they were just mixed together, but there was no separation after convection mixing. Separation occurred after standing for 2 minutes, and the two phases were completely separated after standing for 5 minutes (refer to Figure 1 , the first row of results).
[0083] Test Example 1
[0084] The hydrogel prepared in Example 2 was observed under an electron scanning microscope, and its SEM image is as follows: Figure 2 In addition, the optical microscope image and the fluorescence microscope image of the hydrogel of Example 2 are shown in Figure 8 and Fig. 9 shown.
[0085] from Figure 2 It can be seen that after 3D printing, the hydrogel forms some macroscopic pore structures. In addition, there are a large number of micron-scale pore structures in the hydrogel.
[0086] Test Example 2
[0087] The hydrogels prepared in Examples 2 to 4 were subjected to compression tests on a universal mechanical tester. Specific steps: a 4 mm thick hydrogel was prepared, and a mechanical analyzer was used to study it in an unrestricted compression mode to obtain a stress-strain curve and Young's modulus. The hydrogel was repeatedly compressed 50 times to test the compression resistance of the hydrogel. The obtained stress-strain curve is as follows: Figure 3 The test results of Young's modulus are shown in Figure 4 As shown, Figure 4 0% AM corresponds to the result of Example 4, 2% AM corresponds to the result of Example 2, and 4% corresponds to the result of Example 3.
[0088] from Figure 3 and Figure 4 The results show that when acrylamide (AM) is added to the gel phase, the tensile strength and Young's modulus of the hydrogel can be improved, and the higher the content of acrylamide (AM), the more the tensile strength and Young's modulus are improved, which shows that adding acrylamide (AM) to the gel phase is beneficial to improving the mechanical properties of the hydrogel.
[0089] Test Example 3
[0090] The hydrogels prepared in Examples 2 to 4 were subjected to in vitro degradation experiments in accordance with national standards. The specific method is as follows: a 4 mm thick hydrogel was prepared, the initial mass was recorded, and then it was immersed in PBS buffer, placed in a constant temperature shaker, taken out at regular intervals, freeze-dried, and weighed. The degradation results are shown in Figure 5 As shown, Figure 5 0% AM corresponds to the result of Example 4, 2% AM corresponds to the result of Example 2, and 4% corresponds to the result of Example 3.
[0091] from Figure 5 It can be seen from the results that adding acrylamide (AM) is beneficial to delaying the degradation of hydrogel, and the higher the content of acrylamide (AM), the lower the degree of hydrogel degradation in the same period of time.
[0092] Test Example 4
[0093] The hydrogels prepared in Examples 2 to 4 were observed under a microscope, and the sizes of the pores formed were counted and analyzed. The results are as follows: Figure 6 As shown, Figure 6 0% AM corresponds to the result of Example 4, 2% AM corresponds to the result of Example 2, and 4% corresponds to the result of Example 3.
[0094] from Figure 6 It can be seen from the results that the introduction of 0-0.004 g / ml AM has no effect on the pore structure.
[0095] Test Example 5
[0096] The pore structure distribution of the hydrogels prepared in Example 2, Example 5 and Example 6 was tested, and the results obtained were as follows: Figure 7 shown.
[0097] from Figure 7 It can be seen from the results that when the convective mixing time is longer, the proportion of pores smaller than 50 μm in the pore structure will increase.
[0098] Test Example 6
[0099] The biocompatibility of the hydrogel prepared in Example 2 was tested, and the results are as follows: Fig.10 The specific experimental steps are as follows:
[0100] 1. Preparation of material extract
[0101] Preparation of material culture fluid extract: Prepare the hydrogel aseptically, add the culture fluid at a ratio of 0.1 g / mL, extract in a sealed glass container at 37°C for 24 hours, aspirate the supernatant and filter to obtain a 1 g / ml extract. During the experiment, dilute with cell culture medium to the required concentration.
[0102] 2. Cell Preparation
[0103] The cultured cells were counted and the number of cells was 1×10 6 Calculate the required volume of cell suspension and resuspend the cells in culture medium.
[0104] 3 Add the extract
[0105] Add the resuspended cells to the diluted extracts of different concentrations, add 200uL to each well, add three rows of 96-well plates for each dilution, and add two rows of blank cells. Place the 96-well plates in a 37°C incubator for culture.
[0106] 4. Cell Staining
[0107] Cell live and dead staining: cells cultured for 1, 4, and 7 days were taken and stained using the Calcein-AM / PI cell double staining kit.
[0108] Result analysis: From Fig.10 It can be seen that the hydrogel in Example 2 has good biocompatibility.
[0109] Test Example 7
[0110] The activity and proliferation of the corresponding cells in the hydrogel of Example 2 were tested using the CCK-8 test method ( Fig.11 ), and confocal microscopy was used to observe the extension and proliferation of cells in the hydrogel for 4 and 7 days. The results are as follows Fig.12 and Fig.13The results show that the cells in the hydrogel of Example 2 stretch and proliferate well.
[0111] Test Example 8
[0112] The hydrogel of Example 2 was implanted into the fat layer of experimental rats. The experimental rats were killed 1 week and 2 weeks after implantation, and the implanted sites were sliced and stained for observation. The HE staining results are shown in the figure. Fig.14 shown.
[0113] from Fig.14 It can be seen that the hydrogel has good biocompatibility in vivo (no obvious inflammatory response occurs in mice) and cells can survive in the formed pores.
[0114] The above description is only a specific embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.
Claims
1. A hydrogel precursor solution, characterized in that: It is composed of a mixture of a pore-forming phase and a gel phase; the pore-forming phase contains polyethylene oxide and gelatin, the mass concentration of the polyethylene oxide in the pore-forming phase is 0.016 g / ml, and the mass concentration of the gelatin in the pore-forming phase is 0.05-0.12 g / ml; the gel phase contains methacryloyl gelatin, and the mass concentration of the methacryloyl gelatin in the gel phase is 0.08-0.1 g / ml; the mass ratio of the gel phase to the pore-forming phase is 1:
1.
2. The hydrogel precursor solution according to claim 1, characterized in that: The gelatin in the pore-forming phase is pig skin gelatin.
3. The hydrogel precursor solution according to claim 1 or 2, characterized in that: The gel phase also contains acrylamide and phenyl-2,4,6-trimethylbenzoyl lithium phosphite.
4. The hydrogel precursor solution according to claim 3, characterized in that: The mass concentration of the acrylamide in the gel phase is 0.02 to 0.04 g / ml, and the mass concentration of the phenyl-2,4,6-trimethylbenzoyl lithium phosphite in the gel phase is 0.003 to 0.01 g / ml.
5. The hydrogel precursor solution according to claim 1 or 2, characterized in that: The pore-forming phase is loaded with human adipose stem cells.
6. A method for preparing a hydrogel precursor solution according to any one of claims 1 to 5, characterized in that: The following steps are involved: The pore-forming phase and the gel phase are mixed uniformly to obtain a hydrogel precursor solution.
7. The method for preparing a hydrogel precursor solution according to claim 6, characterized in that: The pore-forming phase is divided into a first portion and a second portion. The first portion of the pore-forming phase is mixed evenly with the gel phase and then mixed with the second portion of the pore-forming phase.
8. A hydrogel, characterized in that The hydrogel precursor solution according to any one of claims 1 to 5 is cross-linked by UV light or 3D printed and then immersed in a culture solution.
9. Use of the hydrogel according to claim 8 in preparing adipose tissue filling and repairing materials, bone repairing materials, articular cartilage repairing materials or wound repairing materials.
Citation Information
Patent Citations
Hydrogel-forming wound dressing or skin coating material
CA1339682C
Hollow porous-gelatin-methylacryloyl-modified phase-change-energy-storage regenerated cellulose fiber and preparing method thereof
CN109825896A
Photo-cross-linking porous hydrogel based on two water-phase immiscible emulsions, preparation method and applications thereof
CN111040199A
Composite hydrogel capable of replacing / repairing temporomandibular joint disc as well as preparation method and application thereof
CN112972775A
Hydrogel composition, hydrogel, bionic cartilage and preparation method and application thereof
CN113440651A
